Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report
JAC-Antimicrobial Resistance · 05.03.2024 · 6 (2)
DOI: 10.1093/jacamr/dlae042 ↗Kurz gefasst
Fallbericht in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 12.03.2024. Verfasst von Giovanni Mori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Ospedale Santa Chiara, Trento, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Unit of Infectious Diseases, Ospedale Santa Chiara, Trento, Italy.
- Università Vita-Salute San Raffaele, Milano, Italy.
- Unit of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy.
ORCID-Profile: Giovanni Mori
Zitieren
APA
Mori, G., Gottardi, M., Guffanti, M., Castagna, A., & Lanzafame, M. (2024). Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report. JAC-Antimicrobial Resistance, 6(2). https://doi.org/10.1093/jacamr/dlae042
Vancouver
Mori G, Gottardi M, Guffanti M, Castagna A, Lanzafame M. Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report. JAC-Antimicrobial Resistance. 2024;6(2). doi:10.1093/jacamr/dlae042
BibTeX
@article{Mori2024,
author = {Mori, Giovanni and Gottardi, Martina and Guffanti, Monica and Castagna, Antonella and Lanzafame, Massimiliano},
title = {Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report},
journal = {JAC-Antimicrobial Resistance},
year = {2024},
volume = {6},
number = {2},
doi = {10.1093/jacamr/dlae042}
}
EUVIMED